Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma-Renewed Enthusiasm and a Lingering Challenge

JAMA Oncol. 2021 Nov 1;7(11):1613-1614. doi: 10.1001/jamaoncol.2021.4410.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Combined Modality Therapy
  • Esophageal Neoplasms* / therapy
  • Esophageal Squamous Cell Carcinoma* / therapy
  • Humans
  • Immunologic Factors
  • Immunotherapy

Substances

  • Immunologic Factors